Groundbreaking $18.5 Billion Collaboration! Stone Pharmaceutical Group Teams up with AstraZeneca to Compete in Weight-Loss Market
January 30, 2026 — 14:20 CST
This Data Is Locked!
This area is available only to Subscribers.
Stone Pharmaceutical Group (1093.HK) announced before market open on January 30th that it has signed a strategic R&D cooperation and authorization agreement with AstraZeneca. The... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals